Zastosowanie w Badaniach Naukowych Produkt przeznaczony jest wycznie do celw laboratoryjnych, dydaktycznych i komercyjnych bada naukowych
Moreover, USP7-mediated decrease of GATA1 poly-ubiquitylation was blocked by the USP7 inhibitors P5091 and P22077 (Figure 5C and Online Supplementary Figure S6B ), demonstrating that the enzymatic activity of USP7 is essential for the USP7-mediated deubiquitylation of GATA1
References 1 AgiusF.Gonzlez-LamotheR.CaballeroJ
Equipment and supplies needed Proper reconstitution requires appropriate equipment
Drugs: OXYGEN (by face mask or nasal cannula) BRONCHODILATORS: Short Acting Beta2 Agonists ( SABAs ): albuterol, levalbuterol Long Acting Beta2 Agonists ( LABAs ): formoterol , salmeterol Antimuscarinics: ipratropium , tiotropium 1) ANTIINFLAMMATORY DRUGS: Corticosteroids ( ICS ): beclomethasone, budesonide, fluticasone, prednisone, prednisolone SMART / COMBINED ICS+FORMOTEROL (Rescue & Control): budesonide + formoterol (Symbicort ) ICS + LABA momentasone + formoterol (Dulera ) ICS + LABA COMBINED ICS + ALBUTEROL (Rescue): budeosnide + albuterol (Airsupra ) ICS + SABA LEUKOTRIENE PATHWAY INHIBITORS: Receptor Antagonists: montelukast , zafirlukast 5-lipoxygentase inhibitor: zileuton ANTI-IgE THERAPY (Allergic asthma) TARGETED BIOLOGIC ANTI-IL THERAPIES (Eosinophilic Asthma / Refractory Asthma): Misc IL-4, IL-5, IL-13 Specific Monoclonal antibodies RARELY USED: cromolyn sodium (low-efficacy degranulation inhibitor) theophylline (low efficacy bronchodilator, life-threatening toxicity, narrow TI) terbutaline (oral & s.c
